Illumina, Inc. (ILMN)
ILMN Stock Price Chart
Explore Illumina, Inc. interactive price chart. Choose custom timeframes to analyze ILMN price movements and trends.
ILMN Company Profile
Discover essential business fundamentals and corporate details for Illumina, Inc. (ILMN) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
IPO Date
28 Jul 2000
Employees
8.97K
Website
https://www.illumina.comCEO
Jacob Thaysen
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements, as well as cancer detection testing services. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. The company was incorporated in 1998 and is based in San Diego, California.
ILMN Financial Timeline
Browse a chronological timeline of Illumina, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 6 May 2026
Upcoming earnings on 4 Feb 2026
Upcoming earnings on 3 Nov 2025
EPS estimate is $1.16.
Earnings released on 31 Jul 2025
EPS came in at $1.19 surpassing the estimated $1.02 by +16.67%, while revenue for the quarter reached $1.06B , missing expectations by -0.57%.
Earnings released on 8 May 2025
EPS came in at $0.97 surpassing the estimated $0.94 by +3.19%, while revenue for the quarter reached $1.04B , beating expectations by +1.52%.
Earnings released on 6 Feb 2025
EPS came in at $0.86 falling short of the estimated $0.92 by -6.52%, while revenue for the quarter reached $1.10B , beating expectations by +3.00%.
Earnings released on 4 Nov 2024
EPS came in at $1.14 surpassing the estimated $0.88 by +29.69%, while revenue for the quarter reached $1.08B , beating expectations by 0.00%.
Earnings released on 6 Aug 2024
EPS came in at $0.36 surpassing the estimated $0.11 by +228.47%, while revenue for the quarter reached $1.11B , beating expectations by +1.73%.
Earnings released on 2 May 2024
EPS came in at $0.09 surpassing the estimated $0.04 by +106.42%, while revenue for the quarter reached $1.08B , beating expectations by +2.44%.
Earnings released on 8 Feb 2024
EPS came in at $0.14 surpassing the estimated $0.02 by +686.08%, while revenue for the quarter reached $1.12B , beating expectations by +3.13%.
Earnings released on 9 Nov 2023
EPS came in at $0.33 surpassing the estimated $0.13 by +153.85%, while revenue for the quarter reached $1.12B , missing expectations by -1.03%.
Earnings released on 9 Aug 2023
EPS came in at $0.32 surpassing the estimated $0.02 by +1.64K%, while revenue for the quarter reached $1.18B , beating expectations by +1.08%.
Earnings released on 25 Apr 2023
EPS came in at $0.08 surpassing the estimated $0.03 by +215.83%, while revenue for the quarter reached $1.09B , missing expectations by -6.82%.
Earnings released on 7 Feb 2023
EPS came in at $0.14 falling short of the estimated $0.19 by -26.32%, while revenue for the quarter reached $1.08B , beating expectations by +1.04%.
Earnings released on 3 Nov 2022
EPS came in at $0.34 surpassing the estimated $0.29 by +17.24%, while revenue for the quarter reached $1.12B , beating expectations by +0.36%.
Earnings released on 11 Aug 2022
EPS came in at $0.57 falling short of the estimated $0.63 by -9.52%, while revenue for the quarter reached $1.16B , missing expectations by -4.90%.
Earnings released on 5 May 2022
EPS came in at $1.07 surpassing the estimated $0.87 by +22.99%, while revenue for the quarter reached $1.22B , beating expectations by +0.32%.
Earnings released on 10 Feb 2022
EPS came in at $0.75 surpassing the estimated $0.49 by +53.06%, while revenue for the quarter reached $1.20B , beating expectations by +6.36%.
Earnings released on 4 Nov 2021
EPS came in at $1.45 surpassing the estimated $1.24 by +16.94%, while revenue for the quarter reached $1.11B , beating expectations by +6.24%.
Earnings released on 5 Aug 2021
EPS came in at $1.87 surpassing the estimated $1.36 by +37.50%, while revenue for the quarter reached $1.13B , beating expectations by +10.64%.
Earnings released on 27 Apr 2021
EPS came in at $1.89 surpassing the estimated $1.36 by +38.97%, while revenue for the quarter reached $1.09B , beating expectations by +18.14%.
Earnings released on 11 Feb 2021
EPS came in at $1.22 surpassing the estimated $1.21 by +0.83%, while revenue for the quarter reached $953.00M , beating expectations by +6.08%.
Earnings released on 29 Oct 2020
EPS came in at $1.02 surpassing the estimated $0.77 by +32.47%, while revenue for the quarter reached $794.00M , beating expectations by +32.47%.
ILMN Stock Performance
Access detailed ILMN performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.